Businessweek Senior Correspondent Wins Wistar Institue Science Journalism Award

Businessweek Senior Correspondent Wins Wistar Institue Science Journalism Award

July 19, 2009

(PHILADELPHIA – July 20, 2009) – The winner of the 2009 Wistar Institute Science Journalism Award is John Carey, senior correspondent in BusinessWeek’s Washington bureau. Carey’s winning entry, which questions whether the benefits of cholesterol-reducing statins like Lipitor are overstated, is titled “Do Cholesterol Drugs Do Any Good?” For his work, he will receive a certificate of award and a cash prize of $5,000. The full text of the article can be read at http://www.businessweek.com/magazine/content/
08_04/b4068052092994.htm.

In announcing the winner, the panel of judges said, “We are pleased to give John Carey of BusinessWeek the 2009 Wistar Institute Science Journalism Award for his article ‘Do Cholesterol Drugs Do Any Good?’ This year saw an exceptionally strong field of entries. We are pleased that, despite industry challenges, there are editors and reporters who are committed to devoting considerable time and space to science and its effect on people’s lives. Carey’s entry stood out because of his willingness to challenge established medical dogma, his skill at scrutinizing statistics, and his ability to demystify those statistics for his readers. We encourage all news organizations to tackle difficult and important topics in biomedical research with the fortitude that Carey displayed.”

John Carey has covered science, technology, medicine, health, and the environment for BusinessWeek since 1989. Prior to BusinessWeek, Carey was an editor of The Scientist and a writer and editor for National & International Wildlife. He spent six years at Newsweek, where he covered science, technology, and health. He has won awards from the Deadline Club, the American Institute of Biological Sciences, the Overseas Press Club, and the Aviation and Space Writers Association. Carey’s recent articles can be viewed on BusinessWeek’s Web site at http://www.businessweek.com/
bios/John_Carey.htm.

The five members of the 2009 judging committee are: Sue Goetinck Ambrose (co-chair), science writer, Dallas Morning News, and winner of the 2004 Wistar Institute Science Journalism Award; Nancy Shute (co-chair), senior writer, U.S. News & World Report; David Baron, health and science editor, “The World,” Public Radio International; Robin Marantz Henig, freelance journalist and contributing writer for The New York Times Magazine; and Jon Palfreman, president, Palfreman Film Group.

The Wistar Institute Science Journalism Award annually honors the most insightful and enterprising reporting on the basic biomedical sciences in print or broadcast journalism. Established in 2004, the prize has established itself as a major award in professional journalism. Submissions for the contest were very competitive this year, as in years past, with 90 strong entries received from top journalists reporting for more than 25 major print and broadcast outlets across the country.

The award acknowledges direct reporting on a significant research advance, exploration of fundamental science underlying a major news story, identification of an emerging trend in scientific thinking, or a thoughtful investigation of the research process. Journalism that expresses the same skepticism encouraged by science itself is given particular attention, as is coverage with the prescience to identify and illuminate the significance of research that may appear, at first glance, to be more limited in scope.

Science journalists working in all media are invited to submit their work for consideration for the 2010 Wistar Institute Science Journalism Award. Up to five stories or broadcast reports from an individual journalist or team of journalists may be submitted as an entry. The work must have been published or broadcast in English between January 1 and December 31, 2009. The deadline for submissions is February 26, 2010.

For more information about the award, visit http://www.wistar.org/news_info/award_Page.html.

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today’s Discoveries – Tomorrow’s Cures. On the Web at www.wistar.org.

# # #